<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.40802.008</object-id><label>Table 1.</label><caption><title>Yeast strains, oligonucleotides and plasmids used in this work.&#160;</title></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="6">Yeast strains</td><td>Name</td><td>Genotype</td><td><bold>Origin</bold></td></tr><tr><td>&#8195;DLY671</td><td><italic>W303-1a trp1&#8710;</italic></td><td>Libri laboratory (BMA64)</td></tr><tr><td>&#8195;DLY2923</td><td><italic>W303-1a ORC2 ORC5 CDC6</italic></td><td>Gift from the Pasero laboratory (PP2583)</td></tr><tr><td>&#8195;DLY2685</td><td><italic>As W303-1a, ORC2 ORC5 cdc6-1</italic></td><td>Gift from the Schwob laboratory (E589)</td></tr><tr><td>&#8195;DLY2687</td><td><italic>As W303-1a, orc2-1 ORC5 CDC6</italic></td><td>Gift from the Schwob laboratory (E1507)</td></tr><tr><td>&#8195;DLY2688</td><td><italic>As W303-1a, ORC2 orc5-1 CDC6</italic></td><td>Gift from the Schwob laboratory (E4649)</td></tr><tr><td rowspan="16">Oligonucleotides</td><td>Name</td><td>Sequence</td><td><bold>Purpose</bold></td></tr><tr><td>&#8195;DL3370</td><td>CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGGCGACGCCCGACGCCGTAATAAC</td><td>Amplification of ARS305 from genomic DNA. Fw primer bearing 48 bp of homology with DL1702.</td></tr><tr><td>&#8195;DL3371</td><td>gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggATATATCAGAAACATACATATG</td><td>Amplification of ARS305 from genomic DNA. Rev primer bearing 50 bp of homology with DL1666.</td></tr><tr><td>&#8195;DL3446</td><td>CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGATATATCAGAAA <break/>CATACATATG</td><td>Insertion of ARS305 in reverse orientation <break/>(compare with primer pair DL3370/DL3371). Rev primer bearing homology with DL1702.</td></tr><tr><td>&#8195;DL3447</td><td>gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggGCG <break/>ACGCCCGACGCCGTAATAAC</td><td>Insertion of ARS305 in reverse orientation (compare with primer pair DL3370/DL3371). Fwd primer bearing homology with DL1666.</td></tr><tr><td>&#8195;DL3581</td><td>gaatctttcttcgaaatcacctttgtatttagcacctgcggttaatgcggGTTTCATGTACTGTCCGGTGTGATT</td><td>Insertion of shortened ARS305, fwd (cf. DL3447). Primes 32 bp downstream B4 element, removing 291 bp of ARS305 &#8220;full-length &#8220;3&#8217; end.</td></tr><tr><td>&#8195;DL3583</td><td>CATCCACAATTACAACCTATACATATTCTAGCTGCCTTCATTGAAACGGAGTATTTGATCCTTTTTTTTATTGTG</td><td>Insertion of shortened ARS305, rev (cf. DL3446). Primes 34 bp upstream ARS305 ACS, removing 83 bp of ARS305 <break/>&#8220;full-length &#8220;5&#8217; end.</td></tr><tr><td>&#8195;DL3376</td><td>TTATTCCTCGAGGACTTTGTAGTTCTTAAAGC</td><td>Insertion of linker substitution Lin102 (B4-) in ARS305 by two stages overlapping PCRs. <break/>Fw primer, <break/>pair with DL3371.</td></tr><tr><td>&#8195;DL3377</td><td>CTACAAAGTCCTCGAGGAATAATAAATCACACCGGAC</td><td>Insertion of linker substitution Lin102 (B4-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.</td></tr><tr><td>&#8195;DL3378</td><td>GGGACCTCGAGGAATACATAACAAAACATATAAAAACC</td><td>Insertion of linker substitution Lin22 (B1-) in ARS305 by two stages overlapping PCRs. Fw primer, pair with DL3371.</td></tr><tr><td>&#8195;DL3379</td><td>GTTATGTATTCCTCGAGGTCCCTTTAATTTTAGGATATG</td><td>Insertion of linker substitution Lin22 (B1-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.</td></tr><tr><td>&#8195;DL3380</td><td>CATAACCCTCGAGGTAAAAACCAACACAATAAAAAAAAGG</td><td>Insertion of linker substitution Lin4 (A-) in ARS305 by two stages overlapping PCRs. Fw primer, pair with DL3371.</td></tr><tr><td>&#8195;DL3381</td><td>GGTTTTTACCTCGAGGGTTATGTATTGTTTATTTTCC</td><td>Insertion of linker substitution Lin4 (A-) in ARS305 by two stages overlapping PCRs. Rev primer, pair with DL3370.</td></tr><tr><td>&#8195;DL1359</td><td>CCTTATACATTAGGTCCTTT</td><td><italic>HSP104</italic> Northern PCR probe, fwd. Primes about 100nt upstream <italic>HSP104</italic> ATG in PTE <break/>TOFF-<italic>HSP104</italic> plasmid serie</td></tr><tr><td>&#8195;DL1360</td><td>ATCCCCCGAATTGATCCGG</td><td><italic>HSP104</italic> Northern PCR probe, rev. Primes upstream BamHI site in PTETOFF-<italic>HSP104</italic> plasmid serie</td></tr><tr><td>&#8195;DL377</td><td>ATGTTCCCAGGTATTGCCGA</td><td><italic>ACT1</italic> Northern PCR probe/RT qPCR amplicon, fwd.</td></tr><tr><td rowspan="15">Oligonucleotides</td><td>&#8195;DL378</td><td>acacttgtggtgaacgatag</td><td><italic>ACT1</italic> Northern PCR probe/RT qPCR amplicon, rev.</td></tr><tr><td>&#8195;DL2627</td><td>ATTCAAAAGCGAACACCGAATTGACCATGAGGAGACGGTCTGGTTTAT</td><td><italic>snR14</italic> Northern oligo probe</td></tr><tr><td>&#8195;DL3763</td><td>CTGGTTGAAACAAATCAGTGCCGGTAAC</td><td>ARS404 qRT-PCR, <break/>amplicon downstream ARS404 ACS. 5&#8217; primes 202 bp <break/>after SSB1 STOP, pair with DL3764.</td></tr><tr><td>&#8195;DL3764</td><td>GACTTTTTCTTAACTAGAATGCTGGAGTAGAAATACGC</td><td>ARS404 qRT-PCR, amplicon downstream ARS404 ACS. 5&#8217; primes 288 bp after SSB1 STOP, pair with DL3763.</td></tr><tr><td>&#8195;DL3767</td><td>CTTTTTAAACTAATATACACATTTTAGCAGATGCG</td><td>ARS404 qRT-PCR, <break/>amplicon upstream ARS404 ACS. 5&#8217; primes 23 bp <break/>after HO STOP, pair with DL3768.</td></tr><tr><td>&#8195;DL3768</td><td>GATGCTGTCCGCGGGCCTCATAAG</td><td>ARS404 qRT-PCR, amplicon upstream ARS404 ACS. 5&#8217; primes60 bp before HO STOP, pair with DL3767.</td></tr><tr><td>&#8195;DL3823</td><td>GGCACTATGCTTTTTAAAATTTTGTTTATACTCAATTTCG</td><td>ARS1004 qRT-PCR, amplicon upstream <break/>ARS1004 ACS. 5&#8217; anneals80 bp after REE1 STOP</td></tr><tr><td>&#8195;DL3824</td><td>GCCCAGTATTTTGTTAACTGTATGGATTGTACTAG</td><td>ARS1004 qRT-PCR, amplicon upstream ARS1004 ACS. 5&#8217; anneals170 bp after REE1 STOP</td></tr><tr><td>&#8195;DL3827</td><td>GTGTTTTAAGATAAAGTGACGAAAGTTAGGGTG</td><td>ARS1004 qRT-PCR, amplicon downstream ARS1004 ACS. 5&#8217; anneals 228 bp after REE1 STOP</td></tr><tr><td>&#8195;DL3828</td><td>CATCATAAGTACTAATTACCACGAATTCAATAATTAGTAAATAC</td><td>ARS1004 qRT-PCR, amplicon downstream ARS1004 ACS. 5&#8217; anneals 318 bp after REE1 STOP</td></tr><tr><td>&#8195;DL187</td><td>ACACActaaattaccggatcaattcgggggatccATGAACGACCAAACGCAATT</td><td>Cloning of <italic>HSP104</italic> in pCM188, fwd.</td></tr><tr><td>&#8195;DL189</td><td>catgatgcggccctcctgcagggccctagcggccgcTTAATCTAGGTCATCATCAA</td><td>Cloning of <italic>HSP104</italic> in pCM188, rev.</td></tr><tr><td>&#8195;DL1124</td><td>taatgaggacagtatggaaattgatgatgacctagattaaTTTAATATAGTGTGATTTTT</td><td>Cloning of <italic>HSP104</italic> 3' UTR in pCM188-<italic>HSP104</italic>, fwd.</td></tr><tr><td>&#8195;DL1125</td><td>ATTACATGATGCGGCCCTCCTGCAGGGCCCTAGCGGCCGCTTTAACATGATTTGGTAGTC</td><td>Cloning of <italic>HSP104</italic> 3' UTR in pCM188-<italic>HSP104</italic>, fwd.</td></tr><tr><td>&#8195;DL4026</td><td>CGTTTATTCCCTTGTTTGATTCAGAAGCAG</td><td>ARS1 KO in pDL214 by <break/>overlapping PCRs, Fwd. Anneals 236 bp after pDL214&#8217;s <break/><italic>URA3</italic> STOP. To be used for both 1 st and 2nd step of the reaction. <break/>During 1 st step, use it in combination with DL4027. During 2nd step, use it in combination with DL4030.</td></tr><tr><td rowspan="10">Oligonucleotides</td><td>&#8195;DL4027</td><td>GCTAGCAAGAATCGGCTCGGGGCTCTCTTGCCTTCCAAC</td><td>ARS1 KO in pDL214 by overlapping PCRs, Rev. Anneals 334 bp after pDL214&#8217;s <italic>URA3</italic> STOP. <break/>To be used during 1 st step in combination with DL4026.</td></tr><tr><td>&#8195;DL4029</td><td>CAAGAGAGCCCCGAGCCGATTCTTGCTAGCCTTTTCTC</td><td>ARS1 KO in pDL214 by overlapping PCRs, Fwd. Anneals 746 bp after pDL214&#8217;s <italic>URA3</italic> STOP. To be used during 1 st step in combination with DL4030.</td></tr><tr><td>&#8195;DL4030</td><td>GATTACGAGGATACGGAGAGAGG</td><td>ARS1 KO in pDL214 by overlapping PCRs, Rev. Anneals 843 bp after pDL214&#8217;s <italic>URA3</italic> STOP. To be used for both 1 st and 2nd step of the reaction. During 1 st step, use it in combination with DL4029. During 2nd step, use it in combination with DL4026.</td></tr><tr><td>&#8195;DL4032</td><td>GTGAAGGAGCATGTTCGGCACAC</td><td>ARS1 KO in pDL214 by overlapping PCRs, Rev sequencing primer. Anneals 1157 bp after pDL214&#8217;s <italic>URA3</italic> STOP.</td></tr><tr><td>&#8195;DL4000</td><td>TTCAAATGTACAGTAACTATCAAAACCATT <break/>ATTGTAGTACCCGTATTCTAATAATGAGCAAAAGAGCTCACATTTTAACG</td><td>Reverse ARS1206 orientation in pDL214, Fwd. <break/>Bears 55 bp of homology with ARS1206 3&#8217; end (+320 to+375 after <italic>HSP104</italic> STOP) followed by 25 bp of homology <break/>to 5&#8217; of T-rich predicted ACS (+102 to+127 after <italic>HSP104</italic> STOP). Pair with DL4001.</td></tr><tr><td>&#8195;DL4001</td><td>TATATATAATTAATAAAACTAATGGAATTTGTTTAATTGAACTTGACACCCGAGCGGACCAATCCGCGTGTGTTTTATAC</td><td>Reverse ARS1206 orientation in pDL214, Rev. Bears 55 bp <break/>of homology with ARS1206 5&#8217; end (+51 to+106 after <italic>HSP104</italic> STOP) followed by 25 bp of homology with 3&#8217; end of ARS1206 (+295 to+320 after <italic>HSP104</italic> STOP). Pair with DL4000.</td></tr><tr><td>&#8195;DL4061</td><td>ATTATTAGAATACGGGTACTAC</td><td>Reverse ARS1206 orientation in pDL214, extension of homology region downstream ARS1206, Fwd. Primes 134 bp upstream <italic>CYC1</italic> terminator. Pair with M13 reverse (DL2163).</td></tr><tr><td>&#8195;DL2163</td><td>caggaaacagctatgac</td><td>Reverse ARS1206 orientation in pDL214, extension of homology region downstream ARS1206, Rev.</td></tr><tr><td>&#8195;DL4066</td><td>GCTCGGGTGTCAAGTTCAATTAAAC</td><td>Reverse ARS1206 orientation in pDL214, extension of homology region <break/>upstream ARS1206, Rev. Primes 106 bp downstream <italic>HSP104</italic> STOP. Pair with DL530.</td></tr><tr><td>&#8195;DL530</td><td>GTTGAATTTAACTCAAGAGGC</td><td>Reverse ARS1206 orientation in pDL214, extension of homology region upstream ARS1206, Fwd. Anneals 2409&#8211;2429 in <break/><italic>HSP104</italic>.</td></tr><tr><td rowspan="6">Oligonucleotides</td><td>&#8195;DL3986</td><td>gctgaagaatgtctggaagttctacc</td><td>Reverse ARS1206 orientation in pDL214, Fwd sequencing primer annealing 108 bp before <italic>HSP104</italic> STOP.</td></tr><tr><td>&#8195;DL163</td><td>acattttcatcacgagatttaccc</td><td>RNase H cleavage assay. <italic>HSP104</italic>, antisense, position 2606&#8211;2583 <break/>from <italic>HSP104</italic> ATG.</td></tr><tr><td>&#8195;DL164</td><td>ttatcgtcatcacctaacgtgtcagcccctatagtagcttcgtgatttggtagaacttcc</td><td>RNase H cleavage assay. <italic>HSP104</italic> Northern oligonucleotide probe, antisense, position 2718&#8211;2631 from <italic>HSP104</italic> ATG.</td></tr><tr><td>&#8195;DL473</td><td>TTTTTTTTTTT <break/>TTTTTTTTT</td><td>RNase H cleavage assay. Poly(dT) oligonucleotide</td></tr><tr><td>&#8195;DL3991</td><td>GATTTGACGTCCAGTGGACTTTTTTGTCC</td><td>RNase H cleavage assay, test<italic>HSP104</italic> readthrough on pDL905, antisense, position 2923&#8211;2895 from<italic>HSP104</italic> ATG</td></tr><tr><td>&#8195;DL3994</td><td>GGAAGTAATAAGTGAAGGTTAAATCTGGACC</td><td>RNase H cleavage assay, test <italic>HSP104</italic> readthrough on pDL907, antisense, position 2909&#8211;2879 from <italic>HSP104</italic> ATG</td></tr><tr><td rowspan="14">&#8195;Plasmids</td><td>Name</td><td>Features</td><td><bold>Reference</bold></td></tr><tr><td>&#8195;pDL454</td><td>PTETOFF-HSP104::Reb1BS::HSP104, PGAL1- <break/>CUP1, 2&#181;, URA3</td><td rowspan="2">Colin et al. <xref ref-type="bibr" rid="bib12">Colin et al., 2014</xref></td></tr><tr><td>&#8195;pDL551</td><td>PTETOFF-HSP104:: <break/>Reb1BS(&#8722;)::HSP104, PGAL1- <break/>CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL790</td><td>PTETOFF-HSP104::ARS305_548 bp::HSP104 <break/>, PGAL1-CUP1, 2&#181;, URA3</td><td rowspan="7">This study</td></tr><tr><td>&#8195;pDL793</td><td>PTETOFF-HSP104::ARS305(A&#8722;)_548 bp::HSP104, <break/>PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL909</td><td>PTETOFF-HSP104:: <break/>ARS305_175 bp::HSP104, <break/>PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL910</td><td>PTETOFF-HSP104:: <break/>ARS305(A&#8722;)_175 bp::HSP104, <break/>PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL911</td><td>PTETOFF-HSP104::ARS305(B1&#8722;)_175 bp::HSP104, PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL912</td><td>PTETOFF-HSP104 <break/>::ARS305(B4&#8722;)_175 bp::HSP104 <break/>, PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL913</td><td>PTETOFF-HSP104 <break/>::ARS305(B1&#8722;B4&#8722;)_175 bp::HSP104, <break/>PGAL1-CUP1, 2&#181;, URA3</td></tr><tr><td>&#8195;pDL30</td><td>PTETOFF-HSP104, <break/>ARS1, CEN4, URA3</td><td rowspan="2">Libri laboratory</td></tr><tr><td>&#8195;pDL214</td><td>PTETOFF-HSP104, <break/>ARS1206, ARS1, CEN4, URA3</td></tr><tr><td>&#8195;pDL905</td><td>PTETOFF-HSP104, ARS1206, &#8710;ars1, CEN4, URA3</td><td rowspan="2">This study</td></tr><tr><td>&#8195;pDL907</td><td>PTETOFF-HSP104, 6021sra, &#8710;ars1, CEN4, URA3</td></tr></tbody></table></table-wrap>